Buffet-style Cu(II) for enhance disulfiram-based cancer therapy

J Colloid Interface Sci. 2022 Oct 15:624:734-746. doi: 10.1016/j.jcis.2022.06.009. Epub 2022 Jun 6.

Abstract

Studies have shown that disulfiram (DSF) can combine with Cu2+ to form bis(N, N-diethyldithiocarbamate) copper(II) complex (CuET) as antitumor drugs. However, there is insufficient endogenous Cu2+ dose to eradicate cancer cells selectively. Inspired by the buffet, we use Cu2+ doped hollow zeolitic imidazolate framework nanoparticles (HZIFCu) as the carrier and equipped with DSF and indocyanine green (ICG) and targeted by folic acid (FA) (D&I@HZIFCu-FA) to enhance DSF-based cancer therapy. D&I@HZIFCu-FA could effectively supply Cu2+ by a buffet-style, assisting the "DSF-to-CuET" transformation in the tumor. Additionally, self-supply Cu2+ could convert H2O2 into ·OH by triggering a Fenton-like reaction for chemo-dynamic therapy, and ICG achieves photothermal therapy for tumors under laser irradiation. This work provides a buffet-style for Cu2+ to make DSF a strong candidate for cancer treatment by combining chemotherapy, chemo-dynamic therapy, and photothermal therapy and inspires more research about its applications in tumor therapy.

Keywords: Chemo-dynamic therapy; Chemotherapy; Disulfiram; Photothermal therapy.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Copper
  • Disulfiram / pharmacology
  • Hydrogen Peroxide
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Copper
  • Hydrogen Peroxide
  • Disulfiram